Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Transplantation|October 1, 1986
Natural killer cell subsets in long-term renal allograft recipients. A phenotypic and functional studyC M Legendre, R D Guttmann, G H YipTransplantation|June 1, 1989
CD4+/Leu-7+ large granular lymphocytes in long-term renal allograft recipients. A subset of atypical T cellsC M Legendre, R D Forbes, R Loertscher, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Two-color immunofluorescence and flow cytometry analysis of lymphocytes in long-term renal allotransplant recipients: identification of a major Leu-7+/Leu-3+ subpopulationC M Legendre, R D Guttmann, S K Hou, et al.Diabetes|June 1, 1988
Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitusC M Legendre, A Schiffrin, G Weitzner, et al.Transplantation|February 1, 1987
Characterization of an expanded large granular lymphocyte subset lacking natural killer activity present in renal allograft recipientsC M Legendre, G H Yip, G A Rodrigues, et al.Transplantation|December 16, 2000
Valaciclovir prophylaxis of cytomegalovirus infection and disease in renal transplantation: an economic evaluationC M Legendre, D J Norman, M R Keating, et al.The New England Journal of Medicine|May 13, 1999
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study GroupD Lowance, H H Neumayer, C M Legendre, et al.The New England Journal of Medicine|June 7, 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndromeC M Legendre, C Licht, P Muus, et al.Pageof 1